Table 3.
Group | CAN* | Population (N) | Prevalence |
---|---|---|---|
Total sample |
427 |
2,092 |
20.41% |
Diabetes mellitus |
148 |
446 |
33.18% |
Hypertension |
280 |
976 |
28.69% |
Metabolic syndrome | 238 | 833 | 28.57% |
*CAN, cardiovascular autonomic neuropathy.
Group | CAN* | Population (N) | Prevalence |
---|---|---|---|
Total sample |
427 |
2,092 |
20.41% |
Diabetes mellitus |
148 |
446 |
33.18% |
Hypertension |
280 |
976 |
28.69% |
Metabolic syndrome | 238 | 833 | 28.57% |
*CAN, cardiovascular autonomic neuropathy.